TABLE 3.
PFGE group | No. of hospitalsa | No. (%) of strains | % of strains belonging to serogroup
|
% of strains belonging to resistance phenotypeb
|
|||||
---|---|---|---|---|---|---|---|---|---|
O:1 | O:6 | O:11 | O:12 | MR | RES | SU | |||
A | 8 | 16 (20) | 12 | 81 | 100 | ||||
B | 9 | 19 (24) | 16 | 16 | 32 | 42 | 32 | 26 | |
C | 7 | 11 (14) | 45 | 9 | 9 | 37 | 54 | ||
D | 4 | 7 (9) | 14 | 43 | 57 | 29 | 14 | ||
E | 3 | 6 (8) | 17 | 83 | 67 | 33 | |||
F | 3 | 4 (5) | 25 | 50 | 50 | 50 | |||
G | 4 | 4 (5) | 50 | 25 | 50 | 50 | |||
Other | 7 | 12 (15) | 8 | 33 | 8 | 42 | 42 | 16 |
Number of hospitals where representative isolates were present.
MR, resistant or intermediately resistant to two or more antibiotic classes; RES, resistant or intermediately resistant to one antibiotic class; SU, susceptible. Calculations are based on the 79 isolates that were typed by PFGE.